Brent L. Larson, EVP, CFO, Treasurer & Sec'y at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), sold 12,500 shares at $1.50 ($19K) on 2015-12-01, disclosed to the SEC on 2015-12-03.
Scheduled sale ($19k) by EVP, CFO, Treasurer & Sec'y under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NAVB | SELL | 2015-09-02 | $24K | — | Filing → |
| NAVB | SELL | 2015-08-05 | $21K | — | Filing → |
| NAVB | SELL | 2015-07-02 | $20K | — | Filing → |